Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Short-Term Debt issuances (2014 - 2022)

Precigen (PGEN) posted quarterly Short-Term Debt issuances of -$115.7 million for Q4 2022, down 3704.18% quarter-over-quarter from $3.2 million in Q2 2020.

Analysis

Precigen (PGEN) Short-Term Debt issuances (2014 - 2022) Analysis & Trends

Precigen (PGEN) has reported Short-Term Debt issuances for 8 consecutive years, with -$115.7 million the latest figure, recorded in Q4 2022.

  • In Q4 2022, Short-Term Debt issuances changed N/A year-over-year to -$115.7 million; the TTM figure through Dec 2022 stood at -$115.7 million (changed N/A YoY), while the FY2020 annual figure was $11.9 million, up 1.45% from the prior year.
  • Short-Term Debt issuances fell to -$115.7 million in Q4 2022 per PGEN's latest filing, from $3.2 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $8.7 million in Q1 2020 and bottomed at -$115.7 million in Q4 2022.
  • Historically, Short-Term Debt issuances has averaged -$7.9 million across 4 years, with a median of $1.3 million in 2018.
  • Annual changes were most pronounced in 2018 — Short-Term Debt issuances slumped 44.88% — and 2020, when it surged 519.18%.
  • Precigen's Short-Term Debt issuances stood at $1.3 million in 2018, then soared by 457.98% to $7.2 million in 2019, then sank by 55.66% to $3.2 million in 2020, then tumbled by 3704.18% to -$115.7 million in 2022.
  • Business Quant data shows PGEN's Short-Term Debt issuances at -$115.7 million in Q4 2022, $3.2 million in Q2 2020, and $8.7 million in Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -115.66 Mn
Jun 30, 2020 2.49 Mn
Mar 31, 2020 9.44 Mn
Dec 31, 2019 7.13 Mn
Sep 30, 2019 1.29 Mn
Jun 30, 2019 1.73 Mn
Mar 31, 2019 1.60 Mn
Dec 31, 2018 1.30 Mn
Sep 30, 2018 986,000.00
Jun 30, 2018 1.04 Mn
Mar 31, 2018 1.24 Mn
Dec 31, 2017 1.34 Mn
Sep 30, 2017 1.29 Mn
Jun 30, 2017 1.77 Mn
Mar 31, 2017 2.09 Mn
Dec 31, 2016 2.76 Mn
Sep 30, 2016 680,000.00
Jun 30, 2016 803,000.00
Mar 31, 2016 837,000.00
Dec 31, 2015 1.43 Mn